The oral antiviral drug molnupiravir by Merck & Co.
Merck & Co.
Posted inOncology, Regulatory
Opdivo and Keytruda: First-line Immunotherapy for Gastric Cancer and Esophageal Cancer
Nivolumab or pembrolizumab should be added to standard chemotherapy to prolong the life of patients with gastric, esophageal, and gastroesophageal junction cancers.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Koselugo: First Drug to Treat Neurofibromatosis
Selumetinib by AstraZeneca powerfully suppresses tumor growth in neurofibromatosis type 1.
Posted inNeuroscience, New Drugs, Regulatory
Dayvigo: New Japanese Drug for Insomnia
Lemborexant by Eisai to help you fall asleep. Chronic sleep loss, go away!
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory
Small Cell Lung Cancer: Let Immunotherapy Help!
A deadly disease and modern pharmacological attempts to treat it.
Posted inInfections, Pharma & Biotech
HIV Treatment: One Pill Once a Week
Lenacapavir plus islatravir is a new level of highly active antiretroviral therapy for human immunodeficiency virus infection. Gilead Sciences and Merck & Co. continue their in-depth scientific research.
Posted inOncology, Research
Not All Cancer Drugs Are Equally Useful
Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.